Yusra B. Medik
Researcher
Also affiliated: Rutgers, The State University of New Jersey (2023–2024); University of North Carolina at Chapel Hill (2018–2024); The University of Texas MD Anderson Cancer Center (2020–2024); Community Medical Center (2022–2024); Carolina Institute for NanoMedicine (2018–2021)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Yusra B. Medik's research investigates the interplay between the gut microbiome, immune responses, and therapeutic outcomes, particularly in the context of cancer and autoimmune diseases. Her work has explored how dietary fiber and probiotics can influence the efficacy of melanoma immunotherapy. Medik has also focused on drug delivery systems, including the co-delivery of chemotherapy agents via dual-drug loaded nanoparticles to enhance chemoradiotherapy for non-small cell lung cancer models. Further research has examined the mechanisms of intestinal toxicity associated with immune checkpoint blockade, identifying the roles of IL-6 and myeloid infiltration. Additionally, her studies have contributed to understanding the immune regulation of Type 1 Diabetes through bioengineered beta cell vaccines and the protective functions of STAT3 in hematopoietic stem cells against autocrine type-I interferon responses. Medik's scholarship metrics include an h-index of 8, with 27 publications and 1,261 citations.
Metrics
- h-index: 8
- Publications: 27
- Citations: 1,370
Selected Publications
-
Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care (2025)
-
Bilateral germ cell tumor of the testis (TGCT): Implications for a stem cell versus genetic origin of cancers. (2025)
Collaboration Network
Top Collaborators
- Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care
- Bilateral germ cell tumor of the testis (TGCT): Implications for a stem cell versus genetic origin of cancers.
- Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care
- Bilateral germ cell tumor of the testis (TGCT): Implications for a stem cell versus genetic origin of cancers.
- Bilateral germ cell tumor of the testis (TGCT): Implications for a stem cell versus genetic origin of cancers.
- Bilateral germ cell tumor of the testis (TGCT): Implications for a stem cell versus genetic origin of cancers.
- Bilateral germ cell tumor of the testis (TGCT): Implications for a stem cell versus genetic origin of cancers.
- Bilateral germ cell tumor of the testis (TGCT): Implications for a stem cell versus genetic origin of cancers.
- Bilateral germ cell tumor of the testis (TGCT): Implications for a stem cell versus genetic origin of cancers.
- Bilateral germ cell tumor of the testis (TGCT): Implications for a stem cell versus genetic origin of cancers.
- Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care
- Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care
- Stem Cell Origin of Cancer: Biological Principles and Clinical Strategies for Chemoprevention and Maintenance Therapy in Cancer Care
Similar Researchers
Based on overlapping research topics